You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中国生命集团(08296.HK)拟不超1080万元收购广东因微约19.46%股权
格隆汇 07-29 23:02

格隆汇7月29日丨中国生命集团(08296.HK)公吿,于2024年7月29日,公司及中科讯达(公司间接全资附属公司)与南岳资产订立股权转让协议。根据股权转让协议,公司及中科讯达有条件同意向南岳资产收购南岳资产出资广东因微缴足股本(相当于广东因微约19.46%股权),最高代价为人民币1080万元,将透过根据特别授权向南岳资产或其代名人发行可换股债券方式偿付。于股权转让协议完成后,中科讯达将持有广东因微约19.46%股权。

广东因微主要从事生物芯片研发、高通量测序、大数据云计算分析及个性化医疗咨询服务。其为国内外医疗机构、体检机构、科研机构、制药公司等提供用于生物研究及临床诊断的生物芯片,并提供相关服务。

集团一直积极寻求多元化其收入来源,以提升股东回报。集团已形成传统殡葬服务、新兴生物科技为主业务格局。集团自2019年初起涉足生物科技业务。

广东因微于2015年由中国顶级生物物理机构的专业科学家团队创立。广东因微主要从事生物芯片研发、高通量测序、大数据云计算分析及个性化医疗咨询服务。近年来,广东因微在肿瘤、心脑血管疾病、糖尿病、神经系统等多种疾病检测生物芯片研发方面取得巨大成功。董事认为,收购事项可进一步提升集团在生物科技行业的科研实力及创新能力,以及丰富集团的产品线,并为集团现有业务带来协同效益。预计实现广东因微的生物芯片产品销售后可落实本公司的投资回报及改善集团的财务表现,旨在实现股东回报最大化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account